Original article Comparative effectiveness of budesonide/ formoterol and fluticasone/salmeterol for COPD management
2011
Objective: To compare the effectiveness of budesonide/formoterol fumarate dihydrate (BFC) and fluticasone propionate/salmeterol (FSC), two combination inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) products approved for the treatment of chronic obstructive pulmonary disease (COPD) in the US with respect to cost, therapy adherence, and related healthcare utilization. The effectiveness of these two treatments has not previously been compared in a US COPD population.
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
27
References
0
Citations
NaN
KQI